Author Title [ Type(Desc)] Year
Filters: First Letter Of Title is G  [Clear All Filters]
Journal Article
Ozeki N, Hase N, Higuchi N, Hiyama T, Yamaguchi H, Kawai R, Matsumoto T, Nakata K, Mogi M. Gelatin scaffold combined with bone morphogenetic protein-4 induces odontoblast-like cell differentiation involving integrin profile changes, autophagy-related gene 10, and Wnt5 sequentially in human induced pluripotent stem cells. Differentiation. 2016;93:1-14.
Cucuiet V, Iliuţ M, Potara M, Magyari K, Tripon S, Soritau O, Maniu D, Astilean S, Focsan M. Gelatin-assisted fabrication of reduced nanographene oxide for dual-modal imaging of melanoma cells. Colloids Surf B Biointerfaces. 2023;231:113546.
Wu Y, Liang H, Luo A, Li Y, Liu Z, Li X, Li W, Liang K, Li J, Liu Z, et al. Gelatin-based 3D biomimetic scaffolds platform potentiates culture of cancer stem cells in esophageal squamous cell carcinoma. Biomaterials. 2023;302:122323.
Dizaj SMaleki, Torab A, Kouhkani S, Sharifi S, Negahdari R, Bohlouli S, Fattahi S, Salatin S. Gelatin-Curcumin Nanocomposites as a Coating for Implant Healing Abutment: In Vitro Stability Investigation. Clin Pract. 2023;13(1):88-101.
Du J, Hu X, Su Y, Wei T, Jiao Z, Liu T, Wang H, Nie Y, Li X, Song K. Gelatin/sodium alginate hydrogel-coated decellularized porcine coronary artery to construct bilayer tissue engineered blood vessels. Int J Biol Macromol. 2022.
Moeinzadeh S, Jabbari E. Gelation characteristics, physico-mechanical properties and degradation kinetics of micellar hydrogels. Eur Polym J. 2015;72:566-576.
Shin S, Brunel LG, Cai B, Kilian D, Roth JG, Seymour AJ, Heilshorn SC. Gelation of Uniform Interfacial Diffusant in Embedded 3D Printing. Adv Funct Mater. 2023;33(50).
Pańczyszyn E, Jaśko M, Miłek O, Niedziela M, Męcik-Kronenberg T, Hoang-Bujnowicz A, Zięba M, Adamus G, Kowalczuk M, Osyczka AM, et al. Gellan gum hydrogels cross-linked with carbodiimide stimulates vacuolation of human tooth-derived stem cells in vitro. Toxicol In Vitro. 2021:105111.
Albrecht FB, Dolderer V, Nellinger S, Schmidt FF, Kluger PJ. Gellan Gum Is a Suitable Biomaterial for Manual and Bioprinted Setup of Long-Term Stable, Functional 3D-Adipose Tissue Models. Gels. 2022;8(7).
Cerqueira MT, da Silva LPereira, Santos TC, Pirraco RP, Correlo VM, Reis RL, Marques AP. Gellan Gum-Hyaluronic Acid Spongy-like hydrogels and cells from adipose tissue synergize promoting neoskin vascularization. ACS Appl Mater Interfaces. 2014.
Zhang B, Luo Y, Zhou X, Gao L, Yin X, Yang H. GelMA micropattern enhances cardiomyocyte organization, maturation, and contraction via contact guidance. APL Bioeng. 2024;8(2):026108.
Huang L, Chen X, Yang X, Zhang Y, Qiu X. GelMA-based hydrogel biomaterial scaffold: A versatile platform for regenerative endodontics. J Biomed Mater Res B Appl Biomater. 2024;112(5):e35412.
Han Y, Dal-Fabbro R, Mahmoud AH, Rahimnejad M, Xu J, Castilho M, Dissanayaka WL, Bottino MC. GelMA/TCP nanocomposite scaffold for vital pulp therapy. Acta Biomater. 2023.
Moccia AA, Hitz F, Hoskins P, Klasa R, Power MM, Savage KJ, Shenkier T, Shepherd JD, Slack GW, Song KW, et al. Gemcitabine, dexamethasone, and cisplatin (GDP) is an effective and well-tolerated salvage therapy for relapsed/refractory diffuse large B-cell lymphoma and Hodgkin lymphoma. Leuk Lymphoma. 2016:1-9.
Chiu C-H, Lin Y-J, Ramesh S, Kuo W-W, Chen M-C, Kuo C-H, Li C-C, Wang T-F, Lin Y-M, Liao P-H, et al. Gemcitabine resistance in non-small cell lung cancer is mediated through activation of the PI3K/AKT/NF-κB pathway and suppression of ERK signaling by reactive oxygen species. J Biochem Mol Toxicol. 2023:e23497.
Huang Y-Y, Kaneko KJ, Pan H, DePamphilis ML. Geminin Is Essential To Prevent DNA Re-Replication Dependent Apoptosis In Pluripotent Cells, But Not In Differentiated Cells. Stem Cells. 2015.
Tabrizi GA, Böse K, Reimann Y, Kessel M. Geminin is required for the maintenance of pluripotency. PLoS One. 2013;8(9):e73826.
Caronna EA, Patterson ES, Hummert PM, Kroll KL. Geminin Restrains Mesendodermal Fate Acquisition of Embryonic Stem Cells and is Associated with Antagonism of Wnt Signaling and Enhanced Polycomb-Mediated Repression. Stem Cells. 2013.
Hawkes EA, Barton S, Cunningham D, Peckitt C, Chua S, Wotherspoon A, Horwich A, Potter M, Ethel M, Dearden C, et al. GEM-P chemotherapy is active in the treatment of relapsed Hodgkin lymphoma. Ann Hematol. 2013.
O'Hear C, Inaba H, Pounds S, Shi L, Dahl G, W Bowman P, Taub JW, Pui C-H, Ribeiro RC, Coustan-Smith E, et al. Gemtuzumab ozogamicin can reduce minimal residual disease in patients with childhood acute myeloid leukemia. Cancer. 2013.
Schlenk RF, Paschka P, Krzykalla J, Weber D, Kapp-Schwoerer S, Gaidzik VI, Leis C, Fiedler W, Kindler T, Schroeder T, et al. Gemtuzumab Ozogamicin in -Mutated Acute Myeloid Leukemia: Early Results From the Prospective Randomized AMLSG 09-09 Phase III Study. J Clin Oncol. 2019:JCO1901406.
Tarlock K, Alonzo TA, Gerbing R, Raimondi SC, Hirsch BA, Sung L, Pollard JA, Aplenc R, Loken MR, Gamis A, et al. Gemtuzumab ozogamicin reduces relapse risk in FLT3/ITD acute myeloid leukemia: a report from the Children's Oncology Group. Clin Cancer Res. 2015.
Thielecke L, Cornils K, Glauche I. genBaRcode - a comprehensive R package for genetic barcode analysis. Bioinformatics. 2019.
Popierz-Rydlewska N, Merkiel-Pawłowska S, Łojko-Dankowska A, Komarnicki M, Chalcarz W. Gender and the length of time since autologous hematopoietic stem cell transplantation-What is their influence on the immune reconstitution in multiple myeloma patients?. PLoS One. 2023;18(12):e0295308.
Dierselhuis MP, Spierings E, Brand R, Hendriks M, Canossi A, Dolstra H, Eliaou J-F, Enczmann J, Gervais T, Kircher B, et al. Gender influences the birth order effect in HLA-identical stem cell transplantation. Blood. 2013;121(23):4809-11.